On the public citation graph

Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model

0 signed · 60 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/eji.200324084openalex-extracted
Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses
inferredcites →https://doi.org/10.1002/j.1460-2075.1992.tb05481.xopenalex-extracted
Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
inferredcites →https://doi.org/10.1007/s00239-004-0046-3openalex-extracted
Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements
inferredcites →https://doi.org/10.1007/s00262-018-2263-4openalex-extracted
Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment
inferredcites →https://doi.org/10.1016/j.bbamcr.2015.11.003openalex-extracted
Tumor microenvironment (TME)-driven immune suppression in B cell malignancy
inferredcites →https://doi.org/10.1016/j.immuni.2004.07.017openalex-extracted
The Immunobiology of Cancer Immunosurveillance and Immunoediting
inferredcites →https://doi.org/10.1016/j.immuni.2007.05.016openalex-extracted
Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
inferredcites →https://doi.org/10.1016/j.immuni.2016.05.001openalex-extracted
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
inferredcites →https://doi.org/10.1016/j.immuni.2019.11.003openalex-extracted
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
inferredcites →https://doi.org/10.1016/j.it.2017.04.004openalex-extracted
Mechanisms of Immune Tolerance in Leukemia and Lymphoma
inferredcites →https://doi.org/10.1016/s0092-8674(88)91043-4openalex-extracted
Introduction of soluble protein into the class I pathway of antigen processing and presentation
inferredcites →https://doi.org/10.1016/s1074-7613(00)80158-2openalex-extracted
Structure and Dimerization of a Soluble Form of B7-1
inferredcites →https://doi.org/10.1016/s1074-7613(04)00050-0openalex-extracted
B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes
inferredcites →https://doi.org/10.1038/328267a0openalex-extracted
A new member of the immunoglobulin superfamily—CTLA-4
inferredcites →https://doi.org/10.1038/85330openalex-extracted
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
inferredcites →https://doi.org/10.1038/nature13954openalex-extracted
PD-1 blockade induces responses by inhibiting adaptive immune resistance
inferredcites →https://doi.org/10.1038/nature19330openalex-extracted
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
inferredcites →https://doi.org/10.1038/nature22079openalex-extracted
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
inferredcites →https://doi.org/10.1038/ncomms14572openalex-extracted
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice
inferredcites →https://doi.org/10.1038/ni.2391openalex-extracted
Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways
inferredcites →https://doi.org/10.1038/nm730openalex-extracted
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
inferredcites →https://doi.org/10.1038/nmeth.3047openalex-extracted
Improved vectors and genome-wide libraries for CRISPR screening
inferredcites →https://doi.org/10.1038/nprot.2010.43openalex-extracted
Detection of Mycoplasma in cell cultures
inferredcites →https://doi.org/10.1038/nprot.2013.143openalex-extracted
Genome engineering using the CRISPR-Cas9 system
inferredcites →https://doi.org/10.1038/nrc3239openalex-extracted
The blockade of immune checkpoints in cancer immunotherapy
inferredcites →https://doi.org/10.1038/nri3129openalex-extracted
Experimental mouse tumour models: what can be learnt about human cancer immunology?
inferredcites →https://doi.org/10.1038/nri3862openalex-extracted
Molecular and cellular insights into T cell exhaustion
inferredcites →https://doi.org/10.1038/s41423-018-0021-3openalex-extracted
Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
inferredcites →https://doi.org/10.1038/s41586-018-0206-zopenalex-extracted
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
inferredcites →https://doi.org/10.1073/pnas.192461099openalex-extracted
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
inferredcites →https://doi.org/10.1073/pnas.85.7.2274openalex-extracted
Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
inferredcites →https://doi.org/10.1080/2162402x.2017.1294299openalex-extracted
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
inferredcites →https://doi.org/10.1080/2162402x.2019.1577127openalex-extracted
SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice
inferredcites →https://doi.org/10.1084/jem.150.3.580openalex-extracted
Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.
inferredcites →https://doi.org/10.1084/jem.167.6.1767openalex-extracted
Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
inferredcites →https://doi.org/10.1084/jem.192.7.1027openalex-extracted
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
inferredcites →https://doi.org/10.1084/jem.20160801openalex-extracted
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
inferredcites →https://doi.org/10.1097/ppo.0b013e3181eacbd8openalex-extracted
Gene Signature in Melanoma Associated With Clinical Activity
inferredcites →https://doi.org/10.1126/science.1202947openalex-extracted
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
inferredcites →https://doi.org/10.1126/science.1258096openalex-extracted
The new frontier of genome engineering with CRISPR-Cas9
inferredcites →https://doi.org/10.1126/science.1840703openalex-extracted
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
inferredcites →https://doi.org/10.1126/science.271.5256.1734openalex-extracted
Enhancement of Antitumor Immunity by CTLA-4 Blockade
inferredcites →https://doi.org/10.1126/science.291.5502.319openalex-extracted
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
inferredcites →https://doi.org/10.1146/annurev-immunol-032414-112049openalex-extracted
Coinhibitory Pathways in Immunotherapy for Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-15-0255openalex-extracted
Classifying Cancers Based on T-cell Infiltration and PD-L1
inferredcites →https://doi.org/10.1158/2326-6066.cir-16-0391openalex-extracted
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
inferredcites →https://doi.org/10.1158/2326-6066.cir-17-0316openalex-extracted
PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface
inferredcites →https://doi.org/10.1158/2326-6066.cir-18-0750openalex-extracted
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
inferredcites →https://doi.org/10.1159/000386035openalex-extracted
The Concept of Immunological Surveillance
inferredcites →https://doi.org/10.1172/jci96061openalex-extracted
PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
inferredcites →https://doi.org/10.1172/jci96113openalex-extracted
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
inferredcites →https://doi.org/10.1182/blood-2009-04-216671openalex-extracted
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
inferredcites →https://doi.org/10.1186/1756-8722-6-74openalex-extracted
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
inferredcites →https://doi.org/10.1186/s13578-018-0232-4openalex-extracted
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
inferredcites →https://doi.org/10.18632/oncotarget.12739openalex-extracted
The concept of immune surveillance against tumors: The first theories
inferredcites →https://doi.org/10.3389/fimmu.2018.01909openalex-extracted
Not All Immune Checkpoints Are Created Equal
inferredcites →https://doi.org/10.3390/cancers7020736openalex-extracted
Lymphoma: Immune Evasion Strategies
inferredcites →https://doi.org/10.4049/jimmunol.0900080openalex-extracted
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
inferredcites →https://doi.org/10.4049/jimmunol.166.9.5557openalex-extracted
Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective “Arming” of Tumor Antigen-Specific CTL
inferredcites →https://doi.org/10.4049/jimmunol.1701302openalex-extracted
A Believer’s Overview of Cancer Immunosurveillance and Immunotherapy
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.